CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients

Luis  Alves; Rachel  Pullen; John R. Hurst; Marc Miravitlles; Victoria Carter; Rongchang  Chen; Amy  Couper; Mark Dransfield; Alexander  Evans; Antony Hardjojo; David  Jones; Rupert Jones; Margee  Kerr; Konstantinos  Kostikas; Jonathan Marshall; Fernando J  Martinez; Marije  van Melle; Marije  van Melle; Ruth B Murray; Shigeo Muro; Clementine  Nordon; Michael  Pollack; Chris Price; Anita Sharma; Dave  Singh; Tonya A Winders; David Price

doi:10.2147/PROM.S296506

CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients

Luis Alves, Rachel Pullen, John R. Hurst, Marc Miravitlles, Victoria Carter, Rongchang Chen, Amy Couper, Mark Dransfield, Alexander Evans, Antony Hardjojo, David Jones, Rupert Jones, Margee Kerr, Konstantinos Kostikas, Jonathan Marshall, Fernando J Martinez , Marije van Melle, Marije van Melle, Ruth B Murray, Shigeo MuroClementine Nordon, Michael Pollack, Chris Price, Anita Sharma, Dave Singh, Tonya A Winders, David Price^* (Corresponding Author)

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

26 Downloads (Pure)

Abstract

The COllaboratioN on QUality improvement initiative for achieving Excellence in STandards of COPD care (CONQUEST) aims to improve the quality of COPD care in primary care. The CONQUEST target population includes patients diagnosed with COPD, and those undiagnosed but with COPD-like exacerbations, who are at high but modifiable risk of COPD exacerbations, increased morbidity, and
mortality. Timely diagnosis and optimized management to reduce these risks is vital. There is a need for a quality improvement program (QIP) that enables long-term improvement of patient clinical outcomes via integration of the program into routine clinical care.
Core to the CONQUEST program is the adoption of four specifically designed, globally applicable, and expert-agreed quality standards(QS) for modifiable high-risk COPD patients. Translation of the QS into clinical practice, and implementation of the QIP, is guided by the CONQUEST global operational
protocol provided to sites meeting the minimum healthcare system requirements. Initial analyses of current practices are conducted to generate baseline assessments of need within healthcare systems and sites looking to implement the QIP. Implementation is supported by the provision of CONQUEST
resources and tools, such as clinical decision support, that promote prompt identification and treatment of patients. Utilization of electronic medical record (EMR) and patient-reported data are integral components of the QIP. Regular, automated collection and analysis of data, combined with a cyclical review of the implementation process, will be conducted for long-term, continuous improvement and health impact evaluation.
The CONQUEST QIP will be an important resource in the identification and management of patients with modifiable high-risk COPD. Embedding the CONQUEST QS into routine clinical practice with regular evaluation and feedback will result in long-term quality of care improvement.

Original language	English
Pages (from-to)	53-68
Number of pages	16
Journal	Patient Related Outcome Measures
Volume	2022
Issue number	13
Early online date	23 Feb 2022
DOIs	https://doi.org/10.2147/PROM.S296506
Publication status	Published - 23 Feb 2022

Bibliographical note

Funding
This study was conducted by Optimum Patient Care Global and the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was co-funded by Optimum Patient Care Global and AstraZeneca. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution.

Acknowledgements
Hana Muellerova, Patrick Darken, Paul Dorinsky, Frank Trudo, and Alex De Giorgio-Miller of AstraZeneca are acknowledged for their contribution to protocol development. Writing, editorial support, and/or formatting assistance in the development of this manuscript was provided by Shilpa Suresh, MSc, of the Observational and Pragmatic Research Institute, Singapore. Professor Dave Singh
is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC).

Keywords

Patient-reported outcome
Patient-reported information
Clinical decision support
Primary care
Quality standards
Integrated care

Access to Document

10.2147/PROM.S296506Licence: CC BY-NC

Alves_etal_PROM_Conquest_A_Quality_VoR
© 2022 Alves et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
Final published version, 5.06 MBLicence: CC BY-NC

Cite this

Alves, L., Pullen, R., Hurst, J. R., Miravitlles, M., Carter, V., Chen, R., Couper, A., Dransfield, M., Evans, A., Hardjojo, A., Jones, D., Jones, R., Kerr, M., Kostikas, K., Marshall, J., Martinez , F. J., van Melle, M., van Melle, M., Murray, R. B., ... Price, D. (2022). CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients. Patient Related Outcome Measures, 2022(13), 53-68. https://doi.org/10.2147/PROM.S296506

Alves, L, Pullen, R, Hurst, JR, Miravitlles, M, Carter, V, Chen, R, Couper, A, Dransfield, M, Evans, A, Hardjojo, A, Jones, D, Jones, R, Kerr, M, Kostikas, K, Marshall, J, Martinez , FJ, van Melle, M, van Melle, M, Murray, RB, Muro, S, Nordon, C, Pollack, M, Price, C, Sharma, A, Singh, D, Winders, TA & Price, D 2022, 'CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients', Patient Related Outcome Measures, vol. 2022, no. 13, pp. 53-68. https://doi.org/10.2147/PROM.S296506

@article{84e52fb2e577459ab8b8250700ce64e0,

title = "CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients",

abstract = "The COllaboratioN on QUality improvement initiative for achieving Excellence in STandards of COPD care (CONQUEST) aims to improve the quality of COPD care in primary care. The CONQUEST target population includes patients diagnosed with COPD, and those undiagnosed but with COPD-like exacerbations, who are at high but modifiable risk of COPD exacerbations, increased morbidity, andmortality. Timely diagnosis and optimized management to reduce these risks is vital. There is a need for a quality improvement program (QIP) that enables long-term improvement of patient clinical outcomes via integration of the program into routine clinical care.Core to the CONQUEST program is the adoption of four specifically designed, globally applicable, and expert-agreed quality standards(QS) for modifiable high-risk COPD patients. Translation of the QS into clinical practice, and implementation of the QIP, is guided by the CONQUEST global operationalprotocol provided to sites meeting the minimum healthcare system requirements. Initial analyses of current practices are conducted to generate baseline assessments of need within healthcare systems and sites looking to implement the QIP. Implementation is supported by the provision of CONQUESTresources and tools, such as clinical decision support, that promote prompt identification and treatment of patients. Utilization of electronic medical record (EMR) and patient-reported data are integral components of the QIP. Regular, automated collection and analysis of data, combined with a cyclical review of the implementation process, will be conducted for long-term, continuous improvement and health impact evaluation.The CONQUEST QIP will be an important resource in the identification and management of patients with modifiable high-risk COPD. Embedding the CONQUEST QS into routine clinical practice with regular evaluation and feedback will result in long-term quality of care improvement.",

keywords = "Patient-reported outcome, Patient-reported information, Clinical decision support, Primary care, Quality standards, Integrated care",

author = "Luis Alves and Rachel Pullen and Hurst, {John R.} and Marc Miravitlles and Victoria Carter and Rongchang Chen and Amy Couper and Mark Dransfield and Alexander Evans and Antony Hardjojo and David Jones and Rupert Jones and Margee Kerr and Konstantinos Kostikas and Jonathan Marshall and Martinez, {Fernando J} and {van Melle}, Marije and {van Melle}, Marije and Murray, {Ruth B} and Shigeo Muro and Clementine Nordon and Michael Pollack and Chris Price and Anita Sharma and Dave Singh and Winders, {Tonya A} and David Price",

note = "Funding This study was conducted by Optimum Patient Care Global and the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was co-funded by Optimum Patient Care Global and AstraZeneca. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution. Acknowledgements Hana Muellerova, Patrick Darken, Paul Dorinsky, Frank Trudo, and Alex De Giorgio-Miller of AstraZeneca are acknowledged for their contribution to protocol development. Writing, editorial support, and/or formatting assistance in the development of this manuscript was provided by Shilpa Suresh, MSc, of the Observational and Pragmatic Research Institute, Singapore. Professor Dave Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). ",

year = "2022",

month = feb,

day = "23",

doi = "10.2147/PROM.S296506",

language = "English",

volume = "2022",

pages = "53--68",

journal = "Patient Related Outcome Measures",

issn = "1179-271X",

number = "13",

}

TY - JOUR

T1 - CONQUEST

T2 - a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients

AU - Alves, Luis

AU - Pullen, Rachel

AU - Hurst, John R.

AU - Miravitlles, Marc

AU - Carter, Victoria

AU - Chen, Rongchang

AU - Couper, Amy

AU - Dransfield, Mark

AU - Evans, Alexander

AU - Hardjojo, Antony

AU - Jones, David

AU - Jones, Rupert

AU - Kerr, Margee

AU - Kostikas, Konstantinos

AU - Marshall, Jonathan

AU - Martinez , Fernando J

AU - van Melle, Marije

AU - Murray, Ruth B

AU - Muro, Shigeo

AU - Nordon, Clementine

AU - Pollack, Michael

AU - Price, Chris

AU - Sharma, Anita

AU - Singh, Dave

AU - Winders, Tonya A

AU - Price, David

N1 - Funding This study was conducted by Optimum Patient Care Global and the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was co-funded by Optimum Patient Care Global and AstraZeneca. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution. Acknowledgements Hana Muellerova, Patrick Darken, Paul Dorinsky, Frank Trudo, and Alex De Giorgio-Miller of AstraZeneca are acknowledged for their contribution to protocol development. Writing, editorial support, and/or formatting assistance in the development of this manuscript was provided by Shilpa Suresh, MSc, of the Observational and Pragmatic Research Institute, Singapore. Professor Dave Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC).

PY - 2022/2/23

Y1 - 2022/2/23

N2 - The COllaboratioN on QUality improvement initiative for achieving Excellence in STandards of COPD care (CONQUEST) aims to improve the quality of COPD care in primary care. The CONQUEST target population includes patients diagnosed with COPD, and those undiagnosed but with COPD-like exacerbations, who are at high but modifiable risk of COPD exacerbations, increased morbidity, andmortality. Timely diagnosis and optimized management to reduce these risks is vital. There is a need for a quality improvement program (QIP) that enables long-term improvement of patient clinical outcomes via integration of the program into routine clinical care.Core to the CONQUEST program is the adoption of four specifically designed, globally applicable, and expert-agreed quality standards(QS) for modifiable high-risk COPD patients. Translation of the QS into clinical practice, and implementation of the QIP, is guided by the CONQUEST global operationalprotocol provided to sites meeting the minimum healthcare system requirements. Initial analyses of current practices are conducted to generate baseline assessments of need within healthcare systems and sites looking to implement the QIP. Implementation is supported by the provision of CONQUESTresources and tools, such as clinical decision support, that promote prompt identification and treatment of patients. Utilization of electronic medical record (EMR) and patient-reported data are integral components of the QIP. Regular, automated collection and analysis of data, combined with a cyclical review of the implementation process, will be conducted for long-term, continuous improvement and health impact evaluation.The CONQUEST QIP will be an important resource in the identification and management of patients with modifiable high-risk COPD. Embedding the CONQUEST QS into routine clinical practice with regular evaluation and feedback will result in long-term quality of care improvement.

AB - The COllaboratioN on QUality improvement initiative for achieving Excellence in STandards of COPD care (CONQUEST) aims to improve the quality of COPD care in primary care. The CONQUEST target population includes patients diagnosed with COPD, and those undiagnosed but with COPD-like exacerbations, who are at high but modifiable risk of COPD exacerbations, increased morbidity, andmortality. Timely diagnosis and optimized management to reduce these risks is vital. There is a need for a quality improvement program (QIP) that enables long-term improvement of patient clinical outcomes via integration of the program into routine clinical care.Core to the CONQUEST program is the adoption of four specifically designed, globally applicable, and expert-agreed quality standards(QS) for modifiable high-risk COPD patients. Translation of the QS into clinical practice, and implementation of the QIP, is guided by the CONQUEST global operationalprotocol provided to sites meeting the minimum healthcare system requirements. Initial analyses of current practices are conducted to generate baseline assessments of need within healthcare systems and sites looking to implement the QIP. Implementation is supported by the provision of CONQUESTresources and tools, such as clinical decision support, that promote prompt identification and treatment of patients. Utilization of electronic medical record (EMR) and patient-reported data are integral components of the QIP. Regular, automated collection and analysis of data, combined with a cyclical review of the implementation process, will be conducted for long-term, continuous improvement and health impact evaluation.The CONQUEST QIP will be an important resource in the identification and management of patients with modifiable high-risk COPD. Embedding the CONQUEST QS into routine clinical practice with regular evaluation and feedback will result in long-term quality of care improvement.

KW - Patient-reported outcome

KW - Patient-reported information

KW - Clinical decision support

KW - Primary care

KW - Quality standards

KW - Integrated care

U2 - 10.2147/PROM.S296506

DO - 10.2147/PROM.S296506

M3 - Article

SN - 1179-271X

VL - 2022

SP - 53

EP - 68

JO - Patient Related Outcome Measures

JF - Patient Related Outcome Measures

IS - 13

ER -

CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this